TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomics
Division of General Internal Medicine
Taipei Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomicspsoriasis,
Chang Gung Medical Foundation Chang Gung Memorial Hospital, Keelung
Division of Dermatology
更新時間：2023-10-24
鐘文宏Chung, Wen-Hung
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
chung1@cgmh.org.tw
Publication
82Publications
41
42. Chung WH, Shih SR, Chang CF, Lin TY, Huang YC, Chang SC, Liu MT, Ko YS, Deng MC, Liau YL, Lin LH, Chen TH, Yang CH, Ho HC, Lin JW, Lu CW, Lu CF, Hung SI*. Clinicopathologic analysis of coxsackievirus A6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis. 2013 Dec 15;208(12):1968-78. (SCI; IF=6.344; Immunology: 20/151; Infectious diseases: 5/83; Microbiology: 14/123)
42
41. Chi MH, Hui RC, Yang CH, Lin JY, Lin YT, Ho HC, Chung WH*, Kuo TT*. Histopathologic Analysis and Clinical Correlation of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). The British journal of dermatology. 2014 Apr;170(4):866-73. (SCI; IF=4.317; Dermatology: 5/61)
43
40. Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, Chen DP, Chang PY, Wu TL, Hung SI*, Chung WH*. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations. J Dermatol Sci. 2014 Feb;73(2):101-9. (SCI; IF=3.739; Dermatology: 7/61)
44
39. Kao WY, Su CW, Huang YS*, Chou YC, Chen YC, Chung WH*, Hou MC, Lin HC, Lee FY, Wu JC. Risk of Oral Anti-fungal Agent-Induced Liver Injury in Taiwanese. Br J Clin Pharmacol. 2014 Jan; 77(1):180-9. (SCI; IF=3.83; Pharmacology & pharmacy: 49/255)
45
38. Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, Tsai SH, Wu TL, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH*, Mockenhaupt M*, Roujeau JC. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J. 2014 Jun;14(3):281-8. (SCI; IF=3.784; Genetics & heredity: 47/166; Pharmacology & pharmacy: 52/255)
46
37. Cho YT, Lin JW, Chen YC, Chang CY, Hsiao CH, Chung WH*, Chu CY*. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. J Am Acad Dermatol. 2014 Mar;70(3):539-48. (SCI; IF=5.621; Dermatology: 3/61)
47
36. Lin YF, Yang CH, Sindy H, Lin JY, Rosaline, Hui CY, Tsai YC, Wu TS, Huang CT, Kao KC, Hu HC, Chiu CH, Hung SI, Chung WH*. Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics. Clin Infect Dis. 2014 May;58(10):1377-85. (SCI; IF=8.376; Immunology: 9/151; Infectious diseases: 2/83; Microbiology:10/123)
48
35. Chung WH*, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, Chen MJ, Lin JY, Hui RCY, Ho JC, Wu WM, ChenTJ, Wu T, WU YR, Hsih MS, TU PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, SHi Y, Wang TH, Chang SS, Tsai SF, Chang CJ, Chang YS, Hung SI*, Taiwan SCAR consortium, and JPDSC. Genetic variants associated with pheytoin-related severe cutaneous adverse reactions. JAMA. 2014 Aug 6;312(5):525-34. (SCI; IF=37.684; Medicine, General & Internal 3/155)
49
34. Chung WH, Chang WC, Stocker SL, Juo CG, Graham GG, Lee MH, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang CH, Chang CJ, Lin YJ, Day RO, Hung SI*. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Ann Rheum Dis. 2014 Aug 12. (SCI; IF=12.384; Rheumatology 1/32)
50
33. Yeh CN, Chung WH, Su SC, Chen YY, Cheng CT, Lin YL, Chang WC, Chung-Yee Hui R, Chiang KC, Chen TW, Jan YY, Chen CW, Chen TJ, Yang CH*, Hung SI*. Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction. J Invest Dermatol. 2014 Nov; 134(11): 2768-75. (SCI; IF=6.915; Dermatology: 1/61)
